Important Registration Dates

Early Registration:

July 16 – September 27, 2024

Advance Registration: 

September 28 – November 1, 2024

Regular Registration: 

November 2 - December 13, 2024

Patient Advocates

SABCS welcomes attendance by patient advocates representing patient advocacy, education, and survivor support organizations. In addition to the scientific sessions, patient advocates are encouraged to attend educational programming hosted by the Alamo Breast Cancer Foundation (ABCF) and network with colleagues in the SABCS Patient Advocate Lounge.

More information, including how to register for the Alamo Advocate Program, can be found below.

Registration Category & Fees

The patient advocate registration category for SABCS is reserved exclusively for patient advocates and is not intended for medical and scientific professionals. Individuals interested in registering under this category either work or volunteer for national not-for-profit patient advocacy organizations that demonstrate a charitable mission, engage in patient advocacy activities, and supports programs, activities, or services that benefit patients with cancer.  

A discounted patient advocate registration rate is available for qualifying patient advocates. During the registration process patient advocates must upload an attestation or letter confirming their role as a patient advocate. Please include a brief overview of your organization and a detailed description of your current and past cancer-related patient advocacy work, as well as your patient advocacy priorities and plans for the future.  Individuals registered under this category are not eligible to receive continuing education credit for their attendance. 

SABCS is pleased to provide patient advocate registration scholarships for complimentary registration to SABCS. Applicants must submit a patient advocate registration scholarship form to be considered for the scholarship. Scholarships are based on need and will be awarded on a rolling basis. Applications must be submitted at least three weeks before the start of the conference. Organizations are limited to two patient advocate registration scholarships per year. Scholarships are non-transferable.

 

Questions? Please contact: advocacy@aacr.org 

Register Today: https://corereg.cmrus.com/sabcs2024

Patient Advocate Registration Scholarship: https://www.surveymonkey.com/r/SABCS24

Patient Advocate Registration Rates

Price

      In-Person

Early

July 16 – September 27, 2024

$75

Advance

September 28 – November 1, 2024

$75

Regular

November 2 - December 13, 2024

$75

Virtual

Early

July 16 – September 27, 2024

$0

Advance

September 28 – November 1, 2024

$0

Regular

November 2 - December 13, 2024

$0

Alamo Advocate Program

Every year, ABCF sponsors a host of special mentoring and education sessions for patient advocates attending SABCS or participating virtually. 

In the Hot Topics Mentoring Sessions, leading experts in the field of breast cancer provide commentary on symposium presentations and respond to advocates’ questions about the relevance of this scientific data. Daily Educational Programs provide additional advocate-focused scientific information. All programming is available on-site and online for virtual registrants and then archived for view on the ABCF YouTube channel.

Please note, registration for the ABCF Patient Advocate Program is separate from SABCS.

Register for the 2024 Alamo Advocate Program: https://www.alamobreastcancer.org/alamo-advocate-program-2024

Learn more about the 2024 Alamo Advocate Program: https://www.alamobreastcancer.org/alamo-advocate-program-2024

27 Years of Advocate Focus

The administration of the Alamo Advocate Program is handled entirely by ABCF. In addition to the free onsite and virtual programming, ABCF awards a limited number of travel grants to patient advocates attending SABCS. Scholars are required to complete preparatory study, attend designated SABCS and AAP sessions, work with a patient advocate mentor, and prepare a paper on a topic covered at the meeting, for distribution to advocates in their home organization and by ABCF.  

Alamo Breast Cancer Foundation

ABCF is a non-profit 501[c]3 organization focused on grassroots advocacy, education, and support. Formed in 1992, ABCF’s mission is to end breast cancer by assisting patients, informing policymakers and expanding knowledge through education and community outreach.

The 1st Annual Advocate Program was held in 1997, in conjunction with the 21st Annual San Antonio Breast Cancer Symposium. From inception, the program has been specially designed to address the needs of patient advocates and those who support them.  Each year travel grants are awarded to a select group of international and national scholars to attend SABCS. ABCF also sponsors mentoring and educational sessions discussed above, which are open to all SABCS registrants and available virtually during the conference and then on the ABCF YouTube channel.

Contact Information:

Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278

Email: info@alamobreastcancer.org

Website Address: www.alamobreastcancer.org

 

Year

Funding Sources

# Travel Grants Applications

# Travel Grants Awarded

Total # Advocate Registration to SABCS®

2024

(AS OF 5/15/2024)

Daiichi Sankyo, Inc. - Eisai, Inc. –Exact Sciences - Genentech, Inc. - San Antonio Breast Cancer Symposium (in kind)

Open Mid-June to Mid-August

18-24 (EST.)

2023

The Joe W and Dorothy Dorsett Brown Foundation – Daiichi Sankyo, Inc. - Eisai, Inc. – Eli Lilly – Exact Sciences - GE Healthcare – Genentech, Inc. - Genomic Health – Menarini Stemline - Merck - Novartis  -Pfizer, Inc. - San Antonio Breast Cancer Symposium (in kind) – Seagen - ViatrisDai

23

12

587

2022

The Joe W and Dorothy Dorsett Brown Foundation – Daiichi Sankyo, Inc. - Eisai, Inc. – Eli Lilly – Exact Sciences - GE Healthcare – Genentech, Inc. - Genomic Health – Menarini Stemline - Merck - Novartis  -Pfizer, Inc. - San Antonio Breast Cancer Symposium (in kind) – Seagen - Viatris

42

15

400

2021 

Agendia - The Joe W and Dorothy Dorsett Brown Foundation – Daiichi Sankyo, Inc. - Eisai, Inc. – Eli Lilly – Exact Sciences - GE Healthcare – Genentech, Inc. - Genomic Health – Merck –Novartis - Pfizer, Inc. - Sanofi—Seatle Genetics – Seno Medical Instruments - San Antonio Breast Cancer Symposium (in kind) - Viatris

 N/A

N/A 

304 

2020 

N/A 

N/A

N/A

 348

2019 

Agendia - AACR – SSP -
 The Joe W and Dorothy Dorsett Brown Foundation - Eisai, Inc. - Genentech, Inc. - BioOncology - Genomic Health - Julie Ann Carpenter Memorial Fund – Mylan - Nektar Therapeutics - Novartis Oncology - Pfizer, Inc. - The Recycledman Foundation - Sanofi-Genzyme - San Antonio Breast Cancer Symposium (in kind) - Seattle Genetics - Syndax Pharmaceuticals - Theresa's Foundation - VisionRT 

 57

 26

 248

2018 

AACR - Arcus BioSciences - Biotheranostics, Inc. - Joe W and Dorothy Dorsett Brown Foundation - Celgene – Eisai, Inc. - Elekta – Genentech, Inc. - Bio Oncology - Genomic Health, Inc. - Julie Ann Carpenter Memorial Fund - Merck & Co Inc. - NanoString Technologies - Nektar Therapeutics - Novartis Oncology - Pfizer, Inc. -  the Recycledman Foundation - San Antonio Breast Cancer Symposium (in kind) - Seattle Genetics - Seno Medical Instruments, Inc. - Syndax Pharma-ceuticals, Inc. -  Theresa's Foundation

 61

25

163 

 2017

AACR - Avon Foundation for Women - Biotheranostics, Inc. - The Joe W. and Dorothy Dorsett Brown Foundation - Cascadian Therapeutics – Eisai, Inc. - Genentech, Inc. - BioOncology Genomic Health Immunomedics - Julie Ann Carpenter Memorial Fund - Merck – NanoStringTechnologies - Nektar Therapeutics - Novartis Oncology-  Pfizer, Inc. - The Recycledman Foundation - Seno Medical Instruments, Inc. - Syndax Pharmaceuticals, Inc. 

73 

 31

222 

2016 

AACR - Amgen Oncology - AstraZeneca Pharma-ceuticals - Avon Foundation for Women – Biotheranos-tics, Inc. - Cascadian Thera-peutics – Eisai - Genentech, Inc. -  BioOncology - Genomic Health - Julie Ann Carpenter Memorial Fund – Lumicell - M-3 Health Communications - NanoString Technologies - Nektar Therapeutics - Novartis Oncology - Pfizer - The Recycled  Man Foundation - Syndax Pharmaceuticals – SABCS - Susan G. Komen  

 63

 34

180 

2015 

AACR - Amgen Oncology - AstraZeneca Pharmaceuticals - Avon Foundation for Women Eisai Inc. - Genentech – ioOncology - Genomic Health, Inc. - Julie Ann Carpenter Memorial Fund - NanoString Technologies - Navidea Biopharmaceuticals - Nektar Therapeutics - Novartis Oncology – Recycledman Foundation – SABCS - Susan G. Komen - Syndax Pharmaceuticals 

71 

28

196